TriCAR-T_CD19

TriCAR-T_CD19 · Timmune Biotech Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TriCAR-T_CD19, covering 2019-09-06 to 2019-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19 [Phase 1, Phase 2]